CIK 0001478320 · Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 270907024
- Phone
- 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,491,115
- in 20 filings, $14.5M under 10b5-1 plans
Net −$33,491,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-10-21 | ROBINS HARLAN S Chief Scientific Officer | Option exercise | +3,700 | $6.55 | $24K | 73,060 |
| 2021-10-21 | ROBINS HARLAN S Chief Scientific Officer | Sale | −3,700 | $33.73 | $125K | 69,360 |
| 2021-10-21 | ROBINS HARLAN S Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −3,700 | 288,800 | ||
| 2021-10-20 | ROBINS HARLAN S Chief Scientific Officer | Option exercise | +3,700 | $6.55 | $24K | 73,060 |
| 2021-10-20 | ROBINS HARLAN S Chief Scientific Officer | Sale | −3,700 | $33.71 | $125K | 69,360 |
| 2021-10-20 | ROBINS HARLAN S Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −3,700 | 292,500 | ||
| 2021-10-19 | ROBINS HARLAN S Chief Scientific Officer | Option exercise | +3,800 | $6.55 | $25K | 73,160 |
| 2021-10-19 | ROBINS HARLAN S Chief Scientific Officer | Sale | −300 | $32.91 | $10K | 72,860 |
| 2021-10-19 | ROBINS HARLAN S Chief Scientific Officer | Sale | −3,500 | $33.76 | $118K | 69,360 |
| 2021-10-19 | ROBINS HARLAN S Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −3,800 | 296,200 | ||
| 2021-10-08 | ADAMS R MARK Chief Operating Officer | Sale | −1,801 | $33.67 | $61K | 51,854 |
| 2021-10-08 | ROBINS HARLAN S Chief Scientific Officer | Option exercise | +3,895 | $6.32 | $25K | 73,255 |
| 2021-10-08 | ROBINS HARLAN S Chief Scientific Officer | Sale | −3,895 | $32.96 | $128K | 69,360 |
| 2021-10-08 | ROBINS HARLAN S Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −3,895 | 70,110 | ||
| 2021-10-07 | ADAMS R MARK Chief Operating Officer | Sale | −1,324 | $32.47 | $43K | 53,655 |
| 2021-10-07 | ROBINS HARLAN S Chief Scientific Officer | Option exercise | +3,895 | $6.32 | $25K | 73,255 |
| 2021-10-07 | ROBINS HARLAN S Chief Scientific Officer | Sale | −200 | $32.50 | $7K | 73,055 |
| 2021-10-07 | ROBINS HARLAN S Chief Scientific Officer | Sale | −3,695 | $33.68 | $124K | 69,360 |
| 2021-10-07 | ROBINS HARLAN S Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −3,895 | 74,005 | ||
| 2021-10-06 | ROBINS HARLAN S Chief Scientific Officer | Option exercise | +3,895 | $6.32 | $25K | 73,255 |
Page 39 of 120 · 2,386 trades